Search

ObjectivesThis scoping review aimed to systematically search, retrieve and map the extent and characteristics of available literature on the evidenced disruptions to medical abortion (MA) medicine procurement caused by the COVID-19 outbreak.DesignScoping review using Arksey and O’Malley’s methodology and Levacet al’s methodological enhancement with adherence to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews.Data sourcesPubMed, Embase, PMC, Science Direct, the Cochrane Library and Google Scholar were searched from January 2020 to April 2022.Eligibility criteriaWe included articles in English that: (1) contained information on MA medicines; (2) included descriptions of procurement disruptions, including those with examples, characteristics and/or statistics; (3) documented events during the COVID-19 pandemic; and (4) presented primary data.Data extraction and synthesisTwo reviewers independently screened search results, performed a full-text review of preliminarily included articles and completed data extraction in a standard Excel spreadsheet. Extracted data from was compared for validation and synthesised qualitatively.ResultsThe two articles included are unpublished grey literature demonstrating evidence of short-lived disruptions in sexual and reproductive health commodity procurement, including MA medicines, in sub-Saharan Africa during the early months of the pandemic. Findings from the two included grey literature articles show that in sub-Saharan contexts, emergency preparedness, stockpiling, adaptations and flexibility of key actors, including donors, alleviated COVID-19 disruptions allowing for resumption of services within weeks.ConclusionThere is a need for increased empirical evidence of MA procurement challenges to understand which barriers to MA procurement may persist and impact continuity of supply while others can fuel resilience and preparedness efforts at the country and subregional levels. The lack of evidence from social marketing organisations and their networks is a significant gap as these actors constitute a vital artery in the distribution of MA commodities in low-income and middle-income countries.

This article shares the authors views that increasing sustainable supply of reproductive health commodities can prevent unintended pregnancies and unsafe abortions averting tens of thousands of maternal deaths annually. The article discusses the factors influencing the attainment of sustainable supply for essential reproductive health commodities to intervene at global and country-levels including the availability of affordable high-quality medicines and supplies; structure of national supply systems; institutionalization of supply; human resource capacity; and stigma. Those active in the field of reproductive health worldwide must take into consideration the commercial availability of commodities; effective financing mechanisms requiring advocacy technical assistance and perseverance; and well-designed and consistently executed forecasting procurement and inventory management practice for supply management.